Regeneron Pharmaceuticals (REGN) Current Leases (2010 - 2026)
Regeneron Pharmaceuticals (REGN) posted quarterly Current Leases of $720.0 million for Q2 2026, little changed quarter-over-quarter from $720.0 million in Q1 2026.
Powered by 
Analysis
Regeneron Pharmaceuticals (REGN) Current Leases (2010 - 2026) Analysis & Trends
Regeneron Pharmaceuticals' Current Leases history runs 8 years deep, the most recent figure standing at $720.0 million for Q2 2026.
- In Q2 2026, Current Leases changed N/A year-over-year to $720.0 million; the TTM figure through Jun 2026 stood at $720.0 million (changed N/A YoY), while the FY2021 annual figure was $719.7 million, changed N/A from the prior year.
- Current Leases for Q2 2026 stood at $720.0 million, roughly flat from $720.0 million in the prior quarter.
- The five-year high for Current Leases was $720.0 million in Q1 2026, with the low at $720.0 million in Q1 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.78 Bn | 130.92 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.50 Bn | 77.51 Bn | 3.93 Bn | 720.00 Mn |
| 3 | Argenx Se | 63.51 Bn | 58.32 Bn | 1.37 Bn | 11.00 Mn |
| 4 | Moderna | 58.06 Bn | 52.92 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 44.04 Bn | 44.04 Bn | - | 16.75 Mn |
| 6 | BeOne Medicines | 40.04 Bn | 34.94 Bn | 1.53 Bn | 21.95 Mn |
| 7 | Alnylam Pharmaceuticals | 35.45 Bn | 32.14 Bn | 992.69 Mn | 45.93 Mn |
| 8 | Royalty Pharma | 28.41 Bn | 27.57 Bn | - | - |
| 9 | Insmed | 27.42 Bn | 26.26 Bn | 358.27 Mn | 6.27 Mn |
| 10 | Incyte | 25.61 Bn | 21.07 Bn | 1.57 Bn | 4.26 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 720.00 Mn |
| Mar 31, 2026 | 720.00 Mn |
| Dec 31, 2021 | 719.70 Mn |
| Sep 30, 2021 | 719.00 Mn |
| Jun 30, 2021 | 718.40 Mn |
| Mar 31, 2021 | 717.80 Mn |
| Dec 31, 2016 | 127.27 Mn |
| Sep 30, 2014 | 1.25 Mn |
| Jun 30, 2014 | 1.06 Mn |
| Mar 31, 2014 | 1.06 Mn |
| Dec 31, 2013 | 939,000.00 |
| Sep 30, 2013 | 794,000.00 |
| Jun 30, 2013 | 794,000.00 |
| Mar 31, 2013 | 1.47 Mn |
| Dec 31, 2012 | 1.37 Mn |
| Sep 30, 2012 | 1.28 Mn |
| Jun 30, 2012 | 1.18 Mn |
| Mar 31, 2012 | 1.09 Mn |
| Dec 31, 2011 | 1.01 Mn |
| Dec 31, 2010 | 675,000.00 |